Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Merck KGaA readies phase III brain cancer trial

June 13, 2011 Research and Development Merck KGaA, brain cancer, cilengitide, glioblastoma

Merck KGaA has completed patient enrollment for a phase III global trial of its first-in-class integrin inhibitor in a rare …
News

Daniel Elger joins e-Therapeutics

June 13, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

UK and India-based e-Therapeutics has appointed Dr Daniel Elger as chief financial officer. He joins the drug discovery company from …
Appointment
EMA's Guido Rasi

Rasi nominated to be EMA chief

June 10, 2011 Research and Development, Sales and Marketing EMA, Guido Rasi, Thomas Lönngren

The European Medicines Agency has nominated Italy’s Guido Rasi to be its next head, after a protracted and messy search. …
News

EU red tape blamed for decline in UK clinical trials

June 10, 2011 Research and Development UK clinical research, clinical trials

Medical and pharma groups have blamed European Union red tape for the decline in the UK as a location for …
News
lilly_andrew_hotchkiss

Lilly promotes Andrew Hotchkiss

June 9, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Lilly has appointed Andrew Hotchkiss president of its operations in Australia, Canada and Europe. Andrew has been with the company …
Appointment

Daiichi Sankyo: Europe poses huge challenge for pharma

June 9, 2011 Research and Development, Sales and Marketing Cancer, Daiichi Sankyo, pricing

Japanese pharma company Daiichi Sankyo is expanding its European operations, creating a new oncology business unit. But outlining its plans …
News
Merck Serono headquarters

Merck Serono signs neurodegenerative collaboration

June 9, 2011 Research and Development Affectis Pharmaceuticals, Merck Serono

Merck Serono has struck a deal with biotech firm Affectis Pharmaceuticals to develop oral neurodegeneration compounds. The companies will commercialise …
News
ABPI's Richard Barker

The Pharmafocus Interview: Richard Barker

June 9, 2011 Research and Development, Sales and Marketing ABPI, Dr Richard Barker, vita

Dr Richard Barker has been at the helm of the UK pharma industry for over six years, but is now …
Feature

Free webinar on An Introduction to Scientific Advice in the EU

June 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Following the success of the recent pharmacovigilance webinars delivered, Wainwright Associates are offering a webinar on An Introduction to Scientific …
News
Press release
oxford_biomedica_alex_lewis

Oxford BioMedica appoints Alex Lewis to strategy role

June 8, 2011 Research and Development appointment, research and development

Oxford, UK-based gene therapy company Oxford BioMedica has appointed Dr Alex Lewis as director of corporate activities and strategy, and …
Appointment
Pfizer OAB clinical trial

Digital Pharma: Pfizer’s mobile-powered ‘virtual’ clinical trial

June 8, 2011 Research and Development Digital Pharma blog, Pfizer, clinical trials

In an industry first Pfizer is to use mobile phone and web-based technology to collect study data for pharma’s first …
News

Roche and Merck collaborate on personalised cancer tests

June 8, 2011 Research and Development Merck, Roche, personalised medicine

Roche has signed a deal to develop diagnostic tests for products in Merck’s oncology pipeline, in a bid to make …
News

Promoting UK biotech’s voice and mission

June 8, 2011 Research and Development ERBI, One Nucleus, biotech

One Nucleus is a new organisation formed from the merger of two of England’s regional networks – ERBI (Eastern Region …
Feature

Merck plans cancer drug submissions later this year

June 7, 2011 Research and Development, Sales and Marketing Merck & Co, ridaforolimus

Merck & Co is to submit its oral investigational cancer drug ridaforolimus to European and US regulators later this year …
News
Merck Serono headquarters

Erbitux meets gold standard in rectal cancer

June 7, 2011 Research and Development, Sales and Marketing Erbitux, Merck Serono, rectal cancer

Studies of Merck Serono’s Erbitux in rectal cancer have shown improved overall survival, a gold standard measure in oncology trials. …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026